To find out if addition of lignocaine 1.5mg/kg IV improves intubating condition compared to rocuronium 0.6mg/kg IV at 60s after induction.
Phase 2
- Conditions
- Health Condition 1: R198- Other specified symptoms and signsinvolving the digestive system and abdomen
- Registration Number
- CTRI/2020/02/023568
- Lead Sponsor
- Amrita hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 18-60years
ASA I-II
Exclusion Criteria
Difficult airway
Patients considered full stomach
Neurological disorders
BMI >30
When intubation lasts for more than 15s
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate if addition of 1.5mg/kg lignocaine improves intubating conditions compared to 0.6mg/kg rocuronium in adults at 60s after induction.Timepoint: February 2020 to August 2020
- Secondary Outcome Measures
Name Time Method To compare the hemodynamic response mean arterial pressure and heart rate between the two groups.Timepoint: February 2020 to August 2020